Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 09/05/2018
Entire Document
 


Case 18-10518-KG     Doc 708     Filed 08/30/18     Page 5 of 11

 

In re: Orexigen Therapeutics, Inc.    Case No. 18-10518 (KG)
Debtor    Reporting Period: July 1, 2018 - July 31, 2018

MOR - 1a

Schedule of Disbursements by Debtor Entity (1)

For the Period: July 1, 2018 - July 31, 2018

(Unaudited)

 

$ USD ‘000s           Cumulative  

Debtor

   July 1, 2018 - July 31, 2018      Since Filing  

Orexigen Therapeutics, Inc.

   $ 63,242      $ 125,582  
  

 

 

    

 

 

 

Total

   $ 63,242      $ 125,582  

Notes:

 

(1) The Schedule of Disbursements is presented on a book basis.